Preliminary experience with direct percutaneous arterial embolisation combined with radiofrequency ablation for hypervascular HCC

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Curley SA, Izzo F, Delrio P, et al. (1999). Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1–8.
   PubMed Web of Science ®Google Scholar
• Gazelle GS, Goldberg SN, Solbiati L, et al. (2000). Tumor ablation with radio-frequency energy. Radiology 217:633–46.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Rhim H, et al. (2007). Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–92.
   PubMed Web of Science ®Google Scholar
• Seror O, N'Kontchou G, Nault JC, et al. (2016). Hepatocellular carcinoma within Milan criteria: No-Touch multibipolar radiofrequency ablation for treatment-long-term results. Radiology 280:611–21.
   PubMed Web of Science ®Google Scholar
• Yang W, Yan K, Goldberg SN, et al. (2016). Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World Journal of Gastroenterology 22:2993–3005.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, et al. (2000). Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214:761–8.
   PubMed Web of Science ®Google Scholar
• Dodd GD, 3rd, Dodd NA, Lanctot AC, et al. (2013). Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology 267:129–36.
   PubMed Web of Science ®Google Scholar
• Tang C, Shen J, Feng W, et al. (2016). Combination therapy of radiofrequency ablation and transarterial chemoembolization for unresectable hepatocellular carcinoma: a retrospective study. Medicine (Baltimore)95:e3754.
   PubMed Web of Science ®Google Scholar
• Kitamoto M, Imagawa M, Yamada H, et al. (2003). Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 181:997–1003.
   PubMed Web of Science ®Google Scholar
• Ernst O, Sergent G, Mizrahi D, et al. (1999). Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172:59–64.
   PubMed Web of Science ®Google Scholar
• Murakami R, Yoshimatsu S, Yamashita Y, et al. (1994). Transcatheter hepatic subsemental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Acta Radiol 35:576–80.
   PubMed Web of Science ®Google Scholar
• Zhang FS, Wu GD, Sun H, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: A single center with 13 years experience. Int J Hyperthermia 30:471–9.
   PubMed Web of Science ®Google Scholar
• Lin CC, Cheng YT, Chen M WT, et al. (2016). The Effectiveness of multiple electrode radiofrequency ablation in patients with hepatocellular carcinoma with lesions more than 3 cm in size and Barcelona Clinic Liver Cancer Stage A to B2. Liver Cancer 5:8–20.
   PubMed Web of Science ®Google Scholar
• Yang W, Chen MH, Yin SS, et al. (2006). Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early and late phase recurrence. Am J Roentgenol 186:S275–83.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. (2004). Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients- mathematic model, overlapping mode, and electrode placement process. Radiology 232:260–71.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. (2006). Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17:671–83.
   PubMed Web of Science ®Google Scholar
• Levy AE, Kowdley KV. (2001). Unresectable hepatocellular carcinoma: the need for an individualized multidisciplinary approach. J Clin Gastroenterol 33:180–2.
   PubMed Web of Science ®Google Scholar
• Bloomston M, Binitie O, Fraiji E, et al. (2002). Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 68:827–31.
   PubMed Web of Science ®Google Scholar
• Rossi S, Garbagnati F, De Francesco L, et al. (1999). Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 85:128–32.
   PubMed Web of Science ®Google Scholar
• Shi F, Zhang L, Li S, et al. (2016). Chemolipiodolization with or without embolization in transcatheter arterial chemoembolization combined with radiofrequency ablation for hepatocellular carcinoma-propensity score matching analysis. Oncotarget 24:31311–21.
   Web of Science ®Google Scholar
• Ryu M, Shmamura Y, Kinoshita T, et al. (1997). Therapeutic results of resection, tanscatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 27:251–7.
   PubMed Web of Science ®Google Scholar
• Siemann DW, Chap lin DJ, Horsman MR. (2004). Vascular-targeting therapies for treatment of malignant disease. Cancer 100:2491–9.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbgel RS. (2005). Angiogenesis as a therapeutic target. Nature 438:967–74.
   PubMed Web of Science ®Google Scholar
• Palma LD. (1998). Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 71:808–18.
   PubMed Web of Science ®Google Scholar
• Yu MH, Kim JH, Yoon JH, et al. (2013). Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI. Am J Roentgenol 201:675–83.
   PubMed Web of Science ®Google Scholar
• Poch FG, Rieder C, Ballhausen H, et al. (2016). The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo. Int J Hyperthermia32:749–56.
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, et al. (2006). Impact of blood flow occlusion on liver necrosis following thermal ablation. ANZ J Surg 76:84–91.
   PubMed Web of Science ®Google Scholar
• Pleguezuelo M, Marelli L, Misseri M, et al. (2008). TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther 8:1623–41.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang ZG, Fu SY, et al. (2016). Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria. Br J Surg 103:348–56.
   PubMed Web of Science ®Google Scholar
• Azuma S, Asahina Y, Nishimura-Sakurai Y, et al. (2016). Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol Res 46:312–19.
   PubMed Web of Science ®Google Scholar
• Bharadwaz A, Bak-Fredslund KP, Villadsen GE, et al. (2016). Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center. Acta Radiol 57:844–51.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Wang MQ, Duan F, et al. (2013). Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas. World J Gastroenterol 19:4192–9.
   PubMed Web of Science ®Google Scholar
• Kubota K, Hisa N, Nishikawa T, et al. (2001). Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26:184–90.
   PubMedGoogle Scholar
• Solbiati L, Livraghi T, Goldberg SN, et al. (2001). Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–66.
   PubMed Web of Science ®Google Scholar